Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration
Priyanshee Gohil, Urvesh D. Patel, Shailesh K. Bhavsar, A. M. Thaker
Abstract
Priyanshee Gohil, Urvesh D. Patel, Shailesh K. Bhavsar, A. M. Thaker
Abstract
Summary Pharmacokinetics of ceftriaxone was studied in buffalo calves (Bubalus bubalis) after single intravenous and intramuscular administration of 10 mg/kg body weight. The drug concentrations in plasma samples were measured by high performance liquid chromatography with UV detection. Following intravenous administration, the drug was rapidly distributed (Cp o : 106.5 ± 9.64 µg/ml; t1/2α: 0.09 ± 0.01 h; Vdarea: 0.48 ± 0.05 L/kg) and eliminated (t1/2β: 1.27 ± 0.04 h) from the body with a clearance rate of 4.40 ± 0.44 ml/min.kg. Following intramuscular administration, the peak plasma concentration of the drug was 15.8 ± 2.4 µg/ml at 0.5 h and the drug was detected up to 12 h. The drug was rapidly absorbed from the site of injection (t1/2ka: 0.35 ± 0.01 h), widely distributed (Vdarea: 1.53 ± 0.2 L/kg) and slowly eliminated from the body (t1/2β: 4.38 ± 0.4 h; ClB: 4.01 ± 0.30 ml/min.kg). The bioavailability of ceftriaxone was 70.2 ± 2.0% following intramuscular injection. Intramuscular injection of ceftriaxone has favourable pharmacokinetics and moderate bioavailability in buffalo calves and can be used for susceptible infections in calves.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Summary Pharmacokinetics of ceftriaxone was studied in buffalo calves (Bubalus bubalis) after single intravenous and intramuscular administration of 10 mg/kg body weight. The drug concentrations in plasma samples were measured by high performance liquid chromatography with UV detection. Following intravenous administration, the drug was rapidly distributed (Cp o : 106.5 ± 9.64 µg/ml; t1/2α: 0.09 ± 0.01 h; Vdarea: 0.48 ± 0.05 L/kg) and eliminated (t1/2β: 1.27 ± 0.04 h) from the body with a clearance rate of 4.40 ± 0.44 ml/min.kg. Following intramuscular administration, the peak plasma concentration of the drug was 15.8 ± 2.4 µg/ml at 0.5 h and the drug was detected up to 12 h. The drug was rapidly absorbed from the site of injection (t1/2ka: 0.35 ± 0.01 h), widely distributed (Vdarea: 1.53 ± 0.2 L/kg) and slowly eliminated from the body (t1/2β: 4.38 ± 0.4 h; ClB: 4.01 ± 0.30 ml/min.kg). The bioavailability of ceftriaxone was 70.2 ± 2.0% following intramuscular injection. Intramuscular injection of ceftriaxone has favourable pharmacokinetics and moderate bioavailability in buffalo calves and can be used for susceptible infections in calves.
Key concepts: Pharmacokinetics, Ceftriaxone, Bubalus, Bioavailability, Intramuscular injection, Medicine, Drug administration, Cmax